Catalyst
Slingshot members are tracking this event:
Valeant Announces FDA Acceptance of BLA Submission for Brodalumab in Moderate-to-Severe Plaque Psoriasis
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| VRX | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jan 25, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Brodalumab, Plaque Psoriasis
